Clinical Pathways Spotlight
This week in health care trends, our oncology clinical pathways spotlight includes articles on the possible future of hospital care, new research and information around breast cancer, and a stem cell transplant startup partners with Harvard Tech.
Melanie Walker, Senior Adviser to the President, World Bank envisions the future of healthcare in the years to come.
This article from Fox News Health shares the exciting news that age doesn’t seem to have an impact on on reconstruction of the breast as previously thought.
This article from The PharmaLetter indicates that advancements in both the cutting-edge science and the treatment outcomes are changing the profile of cancer from life-threatening to chronic disease, transforming cancer care and most importantly increasing the proportion of cancer survivors.
Forbes reports that the startup Magenta Therapeutics has secured $48.5 million to utilize for further development and research to enhance stem cell therapies and transplants for leukemia and lymphoma patients and supply providers with the necessary products.
As reported in Cancer Research UK, the program will analyze the genome and all expressed genes of tumour cells from 250 breast cancer patients to improve diagnosis and tailor treatment.
The articles above are from our dedicated Oncology Clinical Pathways e-magazine. Follow us on Flipboard or Twitter, or just watch for the links to this and our other magazines in our regular weekly BioBlog emails. (Don’t get our emails yet? Subscribe here!)